Analysis of the Current Status and Influencing Factors of Metabolic Syndrome in Patients Undergoing Antiretroviral Therapy for AIDS

Bo TIAN; Yongmei JIN; Haiwen LI; Chongxi LI; Wei ZHANG; Wei GUAN; Haiyun CHEN; Qi XUE; Huirong YANG; Jun LIU

Article Contents

Article Navigation > Journal of Kunming Medical University > 2024 >

Bo TIAN, Yongmei JIN, Haiwen LI, Chongxi LI, Wei ZHANG, Wei GUAN, Haiyun CHEN, Qi XUE, Huirong YANG, Jun LIU. Analysis of the Current Status and Influencing Factors of Metabolic Syndrome in Patients Undergoing Antiretroviral Therapy for AIDS[J]. Journal of Kunming Medical University.

Citation:

PDF( 558 KB)

Analysis of the Current Status and Influencing Factors of Metabolic Syndrome in Patients Undergoing Antiretroviral Therapy for AIDS

Infectious Disease Department，The 3rd People’s Hospital of Kunming/Yunnan Clinical Medical Center for Infectious Diseases，Kunming Yunnan 650041，China

Received Date: 2024-03-25
Available Online: 2024-11-07

Abstract

Abstract

Objective To investigate the current status of metabolic syndrome （MS） in ART patients and analyze its influencing factors. Methods Data from 1972 ART patients were collected and the prevalence of MS was determined according to the diagnostic guidelines. T-tests, chi-square tests, and rank-sum tests were used to compare the differences in the related factors, and the logistic regression was used to analyze the influencing factors. Results Among these patients, 495 （25.05%） met the diagnostic criteria for MS. The risk of MS in males was 2.045 times higher than that in females （P = 0.001）. Patients with elementary or lower education had a higher risk of MS than those with the secondary （P = 0.001） or higher education （P < 0.001）. The risk of developing MS for those over 40 years old was 8.819 times higher than those under 40 years old（P < 0.001）. Smokers had a 1.565 times higher risk of MS compared to non-smokers （P < 0.001）. Patients with BMI≥25 kg/m² （P < 0.001）, fasting glucose≥6.1 mmol/L （P < 0.001）, TG≥1.7 mmol/L （P < 0.001）, HDL-C<1.04 mmol/L （P < 0.001）, and blood pressure≥130/85 mmHg （P < 0.001） were at the higher risk of MS. Pairwise comparisons of the patients using different ART regimens showed that those using integrase inhibitors had a higher incidence of MS （χ² = 17.278, P < 0.001）. Conclusion The prevalence of metabolic syndrome is high among the patients undergoing antiretroviral therapy for AIDS. More interventions and recommendations should be provided to actively reduce and prevent the occurrence of metabolic syndrome. Lifestyle interventions should be a critical part of managing AIDS patients. The focus is on monitoring the blood pressure, blood sugar, and lipid abnormalities, and taking corresponding measures for individualized treatment and management so as to minimize the occurrence of metabolic syndrome.
- HIV AIDS,
- Metabolic syndrome,
- Current status,
- Influencing factors

FullText(HTML)

References(18)

References

[1]	中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)(下)[J]. 中国实用内科杂志,2021,41(9):757-784.
[2]	Naidu S,Ponnampalvanar S,Kamaruzzaman S B,et al. Prevalence of metabolic syndrome among people living with HIV in developing countries: A systematic review[J]. AIDS Patient Care STDS,2017,31(1):1-13. doi: 10.1089/apc.2016.0140
[3]	Rogalska-Plonska M,Grzeszczuk A,Rogalski P,et al. Metabolic syndrome in HIV infected adults in Poland[J]. Kardiol Pol,2018,76(3):548-553. doi: 10.5603/KP.a2017.0249
[4]	中华医学会感染病学分会艾滋病丙型肝炎学组,中国疾病预防控制中心. 中国艾滋病诊疗指南(2021年版)[J]. 中国艾滋病性病,2021,27(11):1182-1201.
[5]	Ang L W,Ng O T,Boudville I C,et al. An observational study of the prevalence of metabolic syndrome in treatment-experienced people living with HIV in Singapore[J]. PLoS One,2021,16(6):e252320.
[6]	Worm S W,Friis-Moller N,Bruyand M,et al. High prevalence of the metabolic syndrome in HIV-infected patients: Impact of different definitions of the metabolic syndrome[J]. AIDS,2010,24(3):427-435. doi: 10.1097/QAD.0b013e328334344e
[7]	Theengh D P,Yadav P,Jain A K,et al. Assessment of metabolic syndrome in HIV-infected individuals[J]. Indian J Sex Transm Dis AIDS,2017,38(2):152-156. doi: 10.4103/ijstd.IJSTD_55_16
[8]	王延雪,胡虹英,李新刚,等. 初治人类免疫缺陷病毒感染者合并代谢综合征及心血管病风险状况及其临床特点分析[J]. 首都医科大学学报,2020,41(1):40-44. doi: 10.3969/j.issn.1006-7795.2020.01.008
[9]	Jantarapakde J,Phanuphak N,Chaturawit C,et al. Prevalence of metabolic syndrome among antiretroviral-naive and antiretroviral-experienced HIV-1 infected Thai adults[J]. AIDS Patient Care STDS,2014,28(7):331-340. doi: 10.1089/apc.2013.0294
[10]	Rebeiro P F,Jenkins C A,Bian A,et al. Risk of incident diabetes mellitus,weight gain,and their relationships with integrase inhibitor-based initial antiretroviral therapy among persons with human immunodeficiency virus in the United States and Canada[J]. Clin Infect Dis,2021,73(7):e2234-e2242. doi: 10.1093/cid/ciaa1403
[11]	Bourgi K,Rebeiro P F,Turner M,et al. Greater weight gain in treatment-naive persons starting dolutegravir-based antiretroviral therapy[J]. Clin Infect Dis,2020,70(7):1267-1274. doi: 10.1093/cid/ciz407
[12]	Hulgan T. Factors associated with insulin resistance in adults with HIV receiving contemporary antiretroviral therapy: A brief update[J]. Curr HIV/AIDS Rep,2018,15(3):223-232. doi: 10.1007/s11904-018-0399-7
[13]	Friis-Moller N,Thiebaut R,Reiss P,et al. Predicting the risk of cardiovascular disease in HIV-infected patients: The data collection on adverse effects of anti-HIV drugs study[J]. Eur J Cardiovasc Prev Rehabil,2010,17(5):491-501. doi: 10.1097/HJR.0b013e328336a150
[14]	Sears S,Buendia J R,Odem S,et al. Metabolic syndrome among people living with HIV receiving medical care in Southern United States: Prevalence and risk factors[J]. AIDS Behav,2019,23(11):2916-2925. doi: 10.1007/s10461-019-02487-8
[15]	Lu W L,Lee Y T,Sheu G T. Metabolic syndrome prevalence and cardiovascular risk assessment in HIV-positive men with and without antiretroviral therapy[J]. Medicina (Kaunas),2021,57(6):578. doi: 10.3390/medicina57060578
[16]	邓琼燕,周仪铖,李零燕,等. 艾滋病患者体重指数与代谢综合征的关系[J]. 临床内科杂志,2021,38(5):322-325. doi: 10.3969/j.issn.1001-9057.2021.05.011
[17]	Ballocca F,D'Ascenzo F,Gili S,et al. Cardiovascular disease in patients with HIV[J]. Trends Cardiovasc Med,2017,27(8):558-563. doi: 10.1016/j.tcm.2017.06.005
[18]	石瑞紫,何纳. HIV感染者代谢综合征及其组分与神经认知损伤关联研究系统综述[J]. 中华疾病控制杂志,2020,24(12):1452-1458.

Relative Articles(20)

Relative Articles

[1]	Yihan LIU, Jun LIU, Yongmei JIN, Bo TIAN, Jinsong BAI. Risk Assessment and Analysis of Risk Factors for Cardiovascular Disease in HIV Antiviral Therapy Patients. Journal of Kunming Medical University, doi: 10.12259/j.issn.2095-610X.S20241022
[2]	Xuelin XIANG, Hongrui ZHAO, Zhongjie WANG, Yu XIA, Min MA, Huadan WANG, Liping. HE. Social Support Status and Influencing Factors of HIV-infected Patients on Antiviral Therapy. Journal of Kunming Medical University, doi: 10.12259/j.issn.2095-610X.S20240924
[3]	Bo TIAN, Jun LIU, Chongxi LI, Wei ZHANG, Meiqin FANG, Haiyun CHEN, Jingping BAI, Xin ZHOU, Lei CHENG, Yongmei JIN. Effect Observation and Influencing Factors Analysis of Rapid Initiation of Antiretroviral Therapy. Journal of Kunming Medical University, doi: 10.12259/j.issn.2095-610X.S20240925
[4]	Bo TIAN, Chongxi LI, Yongmei JIN, Wei GUAN, Haiyun CHEN, Jun LIU. Use and Replacement of Treatment Regimens for AIDS Patients on Antiretroviral Therapy. Journal of Kunming Medical University, doi: 10.12259/j.issn.2095-610X.S20230508
[5]	Diandian ZENG, Bo TIAN, Yongmei JIN, Chongxi LI, Fen TENG, Jun LIU. A Cross-sectional Survey on Quality of Life of AIDS Patients with Different Antiretroviral Regimens in Kunming Area. Journal of Kunming Medical University, doi: 10.12259/j.issn.2095-610X.S20221227
[6]	Bo TIAN, Jun LIU, Haiwen LI, Wei SONG, Haiyun CHEN, Jianjun SUN. Pathogen Distribution and Antimicrobial Susceptibility of Bacterial Bloodstream Infection in AIDS Patients. Journal of Kunming Medical University, doi: 10.12259/j.issn.2095-610X.S20220616
[7]	Bo TIAN, Yinzhong SHEN, Jinsong BAI, Jun LIU, Haiyun CHEN, Jianjun SUN. Clinical Characteristics of Talaromyces Marneffei Disease and Disseminated Nontuberculosis Mycobacterium Disease in AIDS Patients. Journal of Kunming Medical University, doi: 10.12259/j.issn.2095-610X.S20220718
[8]	Le ZHANG, Yuanqiang HE, Jiawei XIA, Shu LIU, Bin BAI, Xing LIU. Effect of Early Interventional Therapy with Bronchoscopic Alveolar Lavage on AIDS Patients Complicated with Severe Pneumonia. Journal of Kunming Medical University, doi: 10.12259/j.issn.2095-610X.S20221120
[9]	Shan HUANG, Song-qin LV, Hong-fen DUAN, Jin-li SHI, Guang-min LI, Gang HUANG, Jia-neng LI, Xiao-fei LI. Cohort Study on the Influence of Opportunistic Infectious Pathogens on the Distribution of Peripheral Blood T Lymphocyte Subsets in Newly Acquired AIDS Patients During Antiretroviral Therapy. Journal of Kunming Medical University, doi: 10.12259/j.issn.2095-610X.S20211128
[10]	Le Xiao Jing , Chen Jie , Zhang Fan , Li Hui Fang . . Journal of Kunming Medical University,
[11]	Zhang Le , Peng Jing , Xia Jia Wei , Yue Yun Xuan . . Journal of Kunming Medical University,
[12]	Wang Wei Bo , Jin Yong Mei , Yang Jun Jie , Qian Li Fang , Fang Mei Qin , Bai Jing Song . Satisfaction Analysis on the Application of Mobile Nursing Station in HIV/AIDS Department. Journal of Kunming Medical University,
[13]	Zhang Lu Ping , Han Yue Hong , Chen Gui Rong , Zhang Wen Jie , Zhao Xia , Yu Xiao Mei . A Study on the Preventive Drugs for Exposure to AIDS. Journal of Kunming Medical University,
[14]	Feng Jun , Wang Shang Wen , Zhang Zheng , Li Yu Ming . Investigation on HIV/AIDS Health Education Demand of Undergraduates from Different Type Universities in Multi-ethnic Frontier Regions. Journal of Kunming Medical University,
[15]	Pan Song Feng . . Journal of Kunming Medical University,
[16]	Zhao Guang Yu . . Journal of Kunming Medical University,
[17]	Fu Zhong Yang . . Journal of Kunming Medical University,
[18]	Shi Chao Kai . . Journal of Kunming Medical University,
[19]	Su Yun Peng . . Journal of Kunming Medical University,
[20]	. . Journal of Kunming Medical University,